Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Fabbiano

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Leukemia & Lymphoma|July 13, 2011
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patientsMichele Malagola, Cristina Skert, Marco Vignetti, et al.
Blood Advances|October 14, 2021
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemiaGiovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, et al.
Blood|October 21, 2011
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeVera Grossmann, Enrico Tiacci, Antony B Holmes, et al.
Blood|August 10, 2019
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemiaAdriano Venditti, Alfonso Piciocchi, Anna Candoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trialRoelof Willemze, Stefan Suciu, Giovanna Meloni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 TrialUwe Platzbecker, Giuseppe Avvisati, Laura Cicconi, et al.
The New England Journal of Medicine|July 12, 2013
Retinoic acid and arsenic trioxide for acute promyelocytic leukemiaFrancesco Lo-Coco, Giuseppe Avvisati, Marco Vignetti, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Leukemia & Lymphoma|July 13, 2011
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: retrospective analysis of 530 patientsMichele Malagola, Cristina Skert, Marco Vignetti, et al.
Blood Advances|October 14, 2021
INCB84344-201: Ponatinib and steroids in frontline therapy for unfit patients with Ph+ acute lymphoblastic leukemiaGiovanni Martinelli, Cristina Papayannidis, Alfonso Piciocchi, et al.
Blood|October 21, 2011
Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotypeVera Grossmann, Enrico Tiacci, Antony B Holmes, et al.
Blood|August 10, 2019
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemiaAdriano Venditti, Alfonso Piciocchi, Anna Candoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2013
High-dose cytarabine in induction treatment improves the outcome of adult patients younger than age 46 years with acute myeloid leukemia: results of the EORTC-GIMEMA AML-12 trialRoelof Willemze, Stefan Suciu, Giovanna Meloni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2016
Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 TrialUwe Platzbecker, Giuseppe Avvisati, Laura Cicconi, et al.
The New England Journal of Medicine|July 12, 2013
Retinoic acid and arsenic trioxide for acute promyelocytic leukemiaFrancesco Lo-Coco, Giuseppe Avvisati, Marco Vignetti, et al.
Pageof 5